Faculty Viewpoints
Who Gets Access to Innovative Treatments?
In this episode of the Health & Veritas podcast, Harlan Krumholz reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID, and Howard Forman reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.
Taking the Pulse
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz check in on new research and health issues in the news, including studies on colonoscopies and the timing of hypertension medication, the state of the monkey pox and polio outbreaks, and the wave of legislation restricting treatment of trans youth.
Saudi Arabia’s Sabotage of the Economy Will Backfire
With its surprise cut in oil production, write Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and Congressman Ro Khanna LAW ’01, Saudi Arabia has chosen to side with the Russian war machine.
The Revolution in Obesity Medication
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz look at the plunging cost of sequencing an individual genome, and the problem of concussions among athletes at all levels. And they’re joined by Dr. Ania Jastreboff, a Yale obesity specialist, to discuss the dramatic results from a new class of drugs that target the brain’s system for regulating body fat.
Improving Healthcare Organizations to Improve Health
In this episode of the Health & Veritas podcast, Harlan Krumholz discusses the problem of “financial toxicity”—how medical bills can wreak havoc in vulnerable patients’ lives. Howard Forman reflects on the protests in Iran and the precariousness of the freedoms we enjoy in the United States. And they are joined by Ingrid Nembhard of the University of Pennsylvania to discuss her work on the organizational factors that shape patient care.
We’ve Got Climate Solutions. Now We Need a Movement.
Most Americans agree that the planet faces dire consequences if we don’t do more to address climate change. Anthony Leiserowitz, director of the Yale Program on Climate Change Communication, outlines how businesses and individuals can push for action.
Lessons on the Role of Business in Society, from a Timber Baron
Yale SOM leadership expert Jeffrey Sonnenfeld remembers George Weyerhaeuser, who led his family’s timber business for decades. He died earlier this year at 95.
The Scientist-Entrepreneur
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz react to President Joe Biden’s declaration that the pandemic is over. Then they’re joined by Jonathan Rothberg, a Yale-trained scientist who has created new methods for sequencing DNA and founded a series of successful biotech companies.
What’s the Right Price for Russia’s Oil?
Negotiation expert Prof. Barry Nalebuff argues that setting the price cap either too high or too low could lead to failure and defeat the effort to make Putin pay for his aggression.
Is COVID Over? It's Complicated.
On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss the confusion over COVID therapeutics, even among professionals. Then they’re joined by Dr. Jeremy Faust, a researcher, emergency physician, and public voice on COVID and other issues—as well as an active choral conductor. They discuss his unusual path, the state of the pandemic, and the importance of understanding “excess mortality.”
